Spots Global Cancer Trial Database for semaxanib
Every month we try and update this database with for semaxanib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma | NCT00003720 | Sarcoma | semaxanib | 18 Years - | Pfizer | |
| SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer | NCT00005822 | Breast Cancer | doxorubicin hyd... semaxanib conventional su... radiation thera... tamoxifen | 18 Years - | Case Comprehensive Cancer Center | |
| SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | NCT00006001 | Colorectal Canc... | semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With Advanced Solid Tumors | NCT00005642 | Unspecified Adu... | semaxanib | 18 Years - | Case Comprehensive Cancer Center | |
| SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors | NCT00005996 | Unspecified Adu... | cisplatin gemcitabine hyd... semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma | NCT00006013 | Multiple Myelom... | semaxanib | 18 Years - | Fox Chase Cancer Center | |
| SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma | NCT00005042 | Sarcoma | semaxanib | 18 Years - | AIDS Malignancy Consortium | |
| SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer | NCT00026260 | Cervical Cancer | semaxanib | - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated | NCT00006003 | Recurrent Melan... Stage IV Melano... | semaxanib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | NCT00023738 | Sarcoma | filgrastim dacarbazine doxorubicin hyd... ifosfamide semaxanib conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | NCT00023738 | Sarcoma | filgrastim dacarbazine doxorubicin hyd... ifosfamide semaxanib conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | NCT00006001 | Colorectal Canc... | semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors | NCT00006000 | Unspecified Adu... | cisplatin irinotecan hydr... semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy | NCT00005942 | Chronic Myelomo... Previously Trea... Recurrent Adult... Refractory Anem... Refractory Anem... | liposomal dauno... semaxanib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With Advanced Solid Tumors | NCT00005642 | Unspecified Adu... | semaxanib | 18 Years - | Case Comprehensive Cancer Center | |
| Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma | NCT00023725 | Sarcoma | semaxanib conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00006002 | Prostate Cancer | dexamethasone semaxanib | 18 Years - | University of Chicago | |
| SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors | NCT00005996 | Unspecified Adu... | cisplatin gemcitabine hyd... semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated | NCT00006003 | Recurrent Melan... Stage IV Melano... | semaxanib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | NCT00004252 | Colorectal Canc... | fluorouracil leucovorin calc... semaxanib | 18 Years - | Pfizer | |
| SU5416 in Treating Children With Recurrent or Progressive Brain Tumors | NCT00006247 | Brain and Centr... | semaxanib | - 21 Years | Pediatric Brain Tumor Consortium | |
| SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer | NCT00005822 | Breast Cancer | doxorubicin hyd... semaxanib conventional su... radiation thera... tamoxifen | 18 Years - | Case Comprehensive Cancer Center | |
| SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck | NCT00005647 | Head and Neck C... | paclitaxel semaxanib | 18 Years - | Case Comprehensive Cancer Center | |
| Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma | NCT00017316 | Melanoma (Skin) | semaxanib thalidomide | 18 Years - | National Cancer Institute (NCI) | |
| Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma | NCT00017316 | Melanoma (Skin) | semaxanib thalidomide | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | NCT00023738 | Sarcoma | filgrastim dacarbazine doxorubicin hyd... ifosfamide semaxanib conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck | NCT00006361 | Carcinoma of Un... Head and Neck C... Non-melanomatou... | semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma | NCT00023725 | Sarcoma | semaxanib conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
